Viridian Therapeutics, Inc. (VRDN)
NASDAQ·Healthcare·Biotechnology
$13.64
+1.04%
Mkt Cap $1.22B
Next Earnings
In 7 daysTue, May 5, 2026
EPS Estimate
-$1.06
8 analysts
Revenue Estimate
$27.75K
Last quarter: missed by -20.00% on EPS, -99.28% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$1.22B
P/E
—
Fwd P/E
—
P/S
17.16
Rev TTM
—
EPS TTM
-$3.32